MARGARET SHARRON: Open Payments
NPI 1477651677 · FLORENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,649 in 75 payments from 18 companies in 2025. Trend: 2023 $1,634 · 2024 $2,272 · 2025 $1,649
Food & beverage: $1,615Education: $34
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $277 |
| AstraZeneca Pharmaceuticals LP | 8 | $233 |
| Amgen Inc. | 7 | $174 |
| CSL Behring | 6 | $169 |
| PFIZER INC. | 6 | $138 |
| GC Biopharma USA, Inc. | 4 | $80 |
| Pharming Healthcare, Inc. | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| GENZYME CORPORATION | 3 | $64 |
Products named: TEZSPIRE, CIBINQO, FASENRA, DUPIXENT, AIRSUPRA, ALYGLO, Rhapsido, RUCONEST.
Industry payments across MA — which companies pay providers there.
